180400 — Dx & Vx Share News
0.000.00%
Last trade - 00:00- KR₩197bn
- KR₩163bn
- KR₩29bn
Development And License Agreement For Mrna Cancer Vaccine With U.S. Biotech Company
Brief: Dx&Vx Accelerates Development of Universal COVID-19 Vaccine
Slovenia's parliament commission rejects former prime minister as central bank governor
Brief: Dx & Vx Co Ltd Wins 10.3 Billion Won Order
Brief: Dx & Vx Co Ltd Wins 5.6 Billion Won Order
Brief: Malaysian Genomics Resource Centre Announces Collaboration Agreement Between unit And Dx&Vx
Brief: Dx&Vx Co Ltd To Conduct Capital Increase Of 50 Billion Won
Brief: DxVx plans to make a license-in agreement of OVM-200 and conduct clinical trials in Asia
Brief: Dx & Vx To Acquire 6 Billion Won Worth Of Shares In Avixgen Inc
Roper Technologies to buy Frontline Education in $3.7 bln deal
Brief: Cancer Rop signs contract worth 1.11 bln won
Brief: Cancer Rop signs contract worth 8.93 bln won
Brief: Cancer Rop issues convertible bonds worth 10 bln won
Brief: MG Med to change company name to Cancer Rop
Brief: MG Med raises 10.0 bln won in private placement
Brief: MG Med proposes name change to Cancer Rop
Brief: MG Med issues 2nd tranche convertible bonds worth 5 bln won
Brief: MG Med issues 1st tranche convertible bonds worth 10 bln won
Brief: MG Med to raise 10 bln won in private placement